CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -99.9% | 3,800 | +533.3% | 0.00% | – |
| Q3 2020 | $4,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 600 | -45.5% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -60.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -90.2% | 1,100 | -94.3% | 0.00% | -100.0% |
| Q2 2019 | $51,000 | +466.7% | 19,400 | +1041.2% | 0.00% | +300.0% |
| Q1 2019 | $9,000 | -50.0% | 1,700 | -29.2% | 0.00% | -50.0% |
| Q4 2018 | $18,000 | – | 2,400 | -11.1% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 2,700 | -50.0% | 0.00% | – |
| Q2 2018 | $5,000 | -58.3% | 5,400 | +315.4% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | +200.0% | 1,300 | +44.4% | 0.00% | – |
| Q4 2017 | $4,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |